Kodak's Q2 Jumped 18%-Now Investors Must Decide If the Balance Sheet Fix Is Real

Q2 improved the narrative, but one strong quarter is not the full test

One strong quarter improved Kodak's story, but the stock still has to pass a basic durability test. The latest call followed a third consecutive quarter of year-over-year revenue, gross profit, and operational EBITDA growth, and the quarter itself was solid: Q2 revenue rose 18% to $311 million, gross profit increased 61% to $82 million, operational EBITDA reached $36 million, and GAAP net income improved to $17 million from a year-ago loss. After a sharp stock move, the real question is no longer whether Kodak can post one good quarter. It is whether the underlying business is improving consistently.

What investors should really judge

The cleanest test is straightforward: are customers buying more, are the products showing real utility, and is management translating demand into cleaner operations? The bullish case has some substance here. Both major operating segments grew: Advanced Materials & Chemicals revenue increased 40% to $105 million, while Commercial Print revenue rose 10% to $195 million, supported by higher volumes and favorable pricing. The balance sheet also looks less strained, with Kodak made $100 million in term-loan repayments during the first half, reduced interest expense, and increased net cash to $180 million from $128 million at year-end 2025.

The counterpoint is just as important. higher aluminum and silver costs, increased SG&A, a $37 million inventory increase, and lower pension income remain financial headwinds. Investors should focus on execution, not brand nostalgia. The decision now is whether this is the start of a real operating repair or simply the first credible sign in a longer turnaround.

The main improvement is balance-sheet relief, not yet a fully proven growth engine

What changed most is not just headline growth. It is that Kodak is reducing financial pressure quickly enough for earnings to matter more than they did before. The most important new development is simpler than the narrative suggests: Kodak made $100 million in term-loan repayments during the first half, reduced interest expense, and increased net cash to $180 million from $128 million at year-end 2025. That shifts the company from a cash-constrained setup toward one where capital allocation can matter again.

Why the debt improvement matters

This is not finance trickery. Lower leverage and better cash positioning can:

• reduce pressure to raise cash on unfavorable terms
• keep more operating cash inside the business
• give management more room to fund priorities without stretching funding

After a strong quarter and a move in the stock, that is the core divide: is this the start of a cleaner cycle, or is this mostly a relief rally?

What looks durable, and what still needs proof

Likely durable - Both major operating segments grew: Advanced Materials & Chemicals revenue increased 40% to $105 million, while Commercial Print revenue rose 10% to $195 million, supported by higher volumes and favorable pricing - Kodak made $100 million in term-loan repayments during the first half, reduced interest expense, and increased net cash to $180 million from $128 million at year-end 2025

Still needs proof - a $37 million inventory increase could reflect demand builders or slower turnover - higher aluminum and silver costs, increased SG&A can pressure margins if they persist - lower pension income is a reminder that some income-line items are outside management's control

If volume and pricing keep showing up while balance-sheet pressure stays lower, the turnaround case gets stronger. If inventory builds and input costs remain high, the quarter may look less decisive than it appears.

The next call needs to show that investment is driving repeat demand

Yesterday's Q2 2026 earnings conference call changed the focus. Kodak no longer needs investors to simply celebrate balance-sheet cleanup. It now needs evidence that the shift toward pharmaceutical products, battery-coating capabilities, motion-picture film, and R&D is supporting real demand and not just improving the optics of the financial statements.

What to watch next

The next update does not need heroic claims. It needs practical confirmation:

• repeat orders from existing customers
• stable or improving segment volumes and pricing
• clearer proof that new spending is supporting demand rather than just extending the growth narrative

If those signals start to appear, the story can evolve from debt relief into something closer to a growth case. If they do not, the stock may still be trading on a balance-sheet repair theme rather than a fully confirmed operating turnaround.